Local Control and Recurrence Patterns after Stereotactic Irradiation Delivered in more than 4 Fractions for Hepatocellular Carcinomas and liver metastases: a retrospective study
Renan A, Bruand M, Jolnerovski M, Diallo A, Demogeot N | Radiat Oncol. | 2025
Fractionated Robotic Radiosurgery for Unfavorable Nonfunctioning Pituitary Macroadenoma: 5-year Outcomes from a Single Institution Protocol
Bhatnagar A, Marin MP, Lischalk JW, Koh MJ, Agazzi S, Suy S, Harris BT, Sharma ST, Aulisi E, Anaizi A, Khattab MH, Jean WC, Collins SP, Collins BT | Front Oncol. | 2025
A Simple Plan Strategy to Optimize the Biological Effective Dose Delivered in Robotic Radiosurgery of Vestibular Schwannomas
Moutsatsos A, Pantelis E | Phys Med Biol. | 2025
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study
Ratnakumaran R, Sasitharan A, Khan A, Mayet H, Mohajer J, Hinder V, Brand DH, Fullarton R, Loblaw A, Hall E, van As N, Tree AC; PACE trial investigators | Int J Radiat Oncol Biol Phys. | 2025
Late Radiation-related Lymphopenia After Prostate Stereotactic Body Radiation Therapy Plus or Minus Supplemental Pelvic Irradiation
Gaudian K, Koh MJ, Koh MJ, Jermain P, Khan I, Kallam D, Lee Z, Collins RR, Zwart Z, Danner M, Zwart A, Kumar D, Atkins MB, Suy S, Collins SP | Front Oncol. | 2024
Results of a Single Arm Phase II Clinical Trial: Online-Adaptive Stereotactic Body Radiotherapy of Abdominal-Pelvic Oligometastases
van Werkhoven LA, Milder MTW, Hoogeman MS, van Werkhoven E, Nout RA, Nuyttens JJ | Int J Radiat Oncol Biol Phys. | 2025
Fractionated Stereotactic Radiotherapy of Brainstem Metastases – Clinical Outcome and Prognostic Factors
Krämer A, Hahnemann L, Schunn F, Grott CA, Thomas M, Christopoulos P, Lischalk JW, Hörner-Rieber J, Hoegen-Saßmannshausen P, Eichkorn T, Deng MY, Meixner E, Lang K, Paul A, Weykamp F, Debus J, König L | Clin Transl Radiat Oncol. | 2025
Robotic Stereotactic Ablative Radiotherapy for Patients with Early-Stage Lung Cancer: Results of an Interim Analysis
Zygogianni A, Koukourakis IM, Georgakopoulos J, Armpilia C, Liakouli Z, Desse D, Ntoumas G, Simopoulou F, Nikoloudi M, Kouloulias V | Cancers (Basel). | 2024
Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas
Wei N, Gunawan K, Tsai CL, Yang SH, Hsu FM, Lai DM, Xiao F | Neurosurgery. | 2025
Stereotactic Body Radiotherapy using CyberKnife Versus Interstitial Brachytherapy in Accelerated Partial Breast Irradiation on Left-sided Breast: A Comparison of Dosimetric Characteristics and Preliminary Clinical Results
Wei TN, Lin JF, Cheng MC, Yeh HL | Breast. | 2024
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
van As N, Yasar B, Griffin C, Patel J, Tree AC, Ostler P, van der Voet H, Ford D, Tolan S, Wells P, Mahmood R, Winkler M, Chan A, Thompson A, Ogden C, Naismith O, Pugh J, Manning G, Brown S, Burnett S, Hall E | Eur Urol. | 2024
Exploring Long-term Outcomes Following CyberKnife Robotic Radiosurgery for Trigeminal Neuralgia
Stergioula A, Moutsatsos A, Pantelis E | Clin Transl Radiat Oncol. | 2024
Robotic Stereotactic Radiotherapy for Intracranial Meningiomas-An Opportunity for Radiation Dose De-Escalation
Grzbiela H, Nowicka E, Gawkowska M, Tarnawska D, Tarnawski R | Cancers (Basel) | 2023
Cochlear-optimized Treatment Planning in Photon and Proton Radiosurgery for Vestibular Schwannoma Patients
Koetsier KS, Oud M, de Klerck E, Hensen EF, van Vulpen M, van Linge A, Paul van Benthem P, Slagter C, Habraken SJM, Hoogeman MS, Méndez Romero A | Clin Transl Radiat Oncol | 2023
CyberKnife Based Fractionated Stereotactic Radiotherapy as an Upfront Treatment for Cerebral Arteriovenous Malformation
Lee J, Kim WC, Kim HJ, Park H. | Clin Neurosci.| 2023
Stereotactic Radiosurgery for Sarcoma Metastases to the Brain: A Single-institution Experience
Zamarud A, Park DJ, Dadey DYA, Yoo KH, Marianayagam NJ, Yener U, Szalkowski GA, Pollom E, Soltys S, Chang SD, Meola A. | Neurosurg Focus. | 2023
Lung-heart Toxicity in a Randomized Clinical Trial of Hypofractionated Image Guided Radiation Therapy for Breast Cancer
Van Parijs H, Cecilia-Joseph E, Gorobets O, Storme G, Adriaenssens N, Heyndrickx B, Verschraegen C, Nguyen NP, De Ridder M, Vinh-Hung V | Front Oncol. | 2025
Toxicity of Dose-escalated, Hypofractionated Helical TomoTherapy for Inoperable Thoracic Esophageal Squamous Cell Carcinoma
Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK | World J Clin Oncol | 2025
Long-term Cardiac Outcomes in Breast Cancer Patients Treated with Helical TomoTherapy: Evaluating the Applicability of 3D-based Dose Constraints for Intensity Modulated Radiation Therapy
Loap P, Uakkas A, Bouziane J, Fourquet A, Kirova Y | Int J Cancer | 2025
Long-term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image-guided Radiotherapy for Postoperative Prostate Cancer Patients
Mukai Y, Omura M, Minagawa Y, Mase M, Nishikawa Y, Miura I, Hata M | Cancer Diagn Progn | 2025
